Learn More
Medchemexpress LLC Istradefylline | 155270-99-8 | 99.9% | 384.43 | 25 MG

Supplier: Medchemexpress LLC 25MGHY10888
Istradefylline is a very potent, selective, and orally active adenosine A2A receptor antagonist, primarily investigated in experimental models of Parkinson's disease. It is intended for research use only.
- Very potent and selective adenosine A2A receptor antagonist.
- Orally active compound.
- Attenuates dopamine and DOPAC depletions in Parkinson's disease models.
- Reverses drug-induced catalepsy and hypokinesia.
- Increases locomotor activity and improves motor disability in MPTP-treated marmosets.
- Shows potentially additive effects with L-DOPA on locomotor activity without increasing dyskinesia.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.